Ardigen and DKFZ research groups are entering into a collaboration to evaluate the safety of TCR-based therapies (TCR-Ts)

Ardigen and DKFZ research groups are entering into a collaboration to evaluate the safety of TCR-based therapies (TCR-Ts)

Related Keywords

Germany ,Heidelberg ,Baden Wüberg ,Mannheim ,German ,Michael Platten ,Edward Green ,Agnieszka Blum ,Przemyslaw Milosemail ,See Campaign ,Edward Green Research Groups ,Head Of Department Brain Tumor Immunology ,German Cancer Research Center ,Heidelberg University ,Ardimmune Tox ,Executive Vice President ,Brain Tumor Immunology ,Medical Faculty Mannheim ,German Cancer Research ,Drug Discovery ,Marketing Managertags ,Google News ,Extended Distribution ,Icrowd News Wire ,Research ,Based Therapies ,Cr Based ,Safety ,Groups ,Kfz Research ,